Skip to main content
Clinical Trials/JPRN-jRCTb070200009
JPRN-jRCTb070200009
Suspended
Phase 2

Clinical reserch of the efficacy of Adipose derived stem cell for liver cirrhosis - ADSC-LC

Itano Satoshi0 sites6 target enrollmentApril 22, 2020
Conditionsiver cirrhosis

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
iver cirrhosis
Sponsor
Itano Satoshi
Enrollment
6
Status
Suspended
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 22, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Itano Satoshi

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria
  • 1\.Clinically diagnosed as cirrhosis by CT and blood tests.
  • 2\.Child\-Pugh score must be 6 points or more.
  • 3\.Must be between 20 and 90 years old.
  • 4\.Prior written consent to participate in the study must be obtained in writing.

Exclusion Criteria

  • Exclusion criteria
  • A. Patients whose abstinence cannot be expected during the treatment period
  • B. Patients with severe heart disease (obvious heart failure and arrhythmia)
  • C. Patients with hypersensitivity to the anesthetic used when collecting adipose tissue
  • D. Patients with uncontrolled malignant or intraepithelial neoplasia
  • E. Patients with uncontrollable infections
  • F. Pregnant women, lactating and possibly pregnant
  • G. Patients taking birth control pills
  • H. Patients who cannot give their informed consent
  • I. Patients who cannot evaluate the efficacy

Outcomes

Primary Outcomes

Not specified

Similar Trials